Skip to main content

Table 2 The incidence rate of the tumour at different sites

From: The role of the AMOP domain in MUC4/Y-promoted tumour angiogenesis and metastasis in pancreatic cancer

Group Organ Malignant Ascites (%)
Pancreas Liver Spleen Peritoneum Mesentery Lung
PANC-MUC4/Y vs PANC-EV 8/8 vs 8/8 8/8 vs 1/8 8/8 vs 8/8 4/8 vs 1/8 4/8 vs 0/8 5/8 vs 0/8 4/8 vs 0/8
P > 0.05 P < 0.01 P > 0.05 P > 0.05 P < 0.05 P < 0.05 P < 0.05
PANC-MUC4/Y vs PANC-MUC4/Y-AMOPΔ 8/8 vs 8/8 8/8 vs 2/8 8/8 vs 8/8 4/8 vs 1/8 4/8 vs 0/8 5/8 vs 0/8 4/8 vs 0/8
P > 0.05 P < 0.01 P > 0.05 P > 0.05 P < 0.05 P < 0.05 P < 0.05
PANC-EV vs PANC-MUC4/Y-AMOPΔ 8/8 vs 8/8 1/8 vs 2/8 8/8 vs 8/8 1/8 vs 1/8 0/8 vs 0/8 0/8 vs 0/8 0/8 vs 0/8
P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05